Type 2 diabetes

DDP4 inhibitors: call to intervene in suboptimal levels of adherence

Adherence to and persistence with DDP4 inhibitors in patients with type 2 diabetes is suboptimal in the real world, according to a systematic review and meta-analysis. Comprising 34 cohort studies and 594,138 patients from ten countries, the study found medication adherence was 56.9% at one year and 44.2% at two years. Persistence with DPP4 inhibitors ...

Already a member?

Login to keep reading.

© 2021 the limbic